ENVB
NSCEnveric Biosciences Inc.
Manufacturing•Semiconductor and Related Device Manufacturing
Watchlists:
Last updated: Monday 21st July 2025
1.32
+0.04 (3.13%)
Prev Close:1.28
Open:1.29
Bid:1.32
Ask:1.33
52 Week Range
1.01173.25
Volume:195,555
Mkt Cap:3 M
30
MarketXLS Rank ®
Weak Hold
Price Target
$1.52
+15.2%
Valuation
Range data not available
Returns
-1.49%
3.94%
10.92%
-81.12%
-98.87%
-99.98%
-98.36%
Risk
Risk Metrics
Financial Scores
0.00
0.00
Ranks
Financial Scores
Risk Metrics
Dividends
Dividend Metrics
Dividend Yields
Analyst Estimates
EPS Estimates
Target Prices
Growth Estimates
Financial Health
Cash Metrics
Liquidity Ratios
4.10
3.60
Debt Metrics
Other Metrics
Financial Scores
Technicals
Technical Oscillators
Moving Averages
Volatility Metrics
Growth
EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A
Profitability
Return Ratios
Margin Ratios
Financial Scores
Peers
Financial Statements
ENVB - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accretion On Preferred Stock | 147988.0 | 295976.0 | ||||||||
| Accrued Preferred Stock Dividends | 19041.0 | 33014.0 | 426003.0 | 3 M | 2 M | |||||
| Acquisition Expense | 333237.0 | |||||||||
| Depletion | 32 M | |||||||||
| Depreciation And Amortization | 337489.0 | 343982.0 | 327910.0 | 656643.0 | 120872.0 | 2 M | 3 M | 3 M | 1 M | |
| Earnings From Equity Interest | -410817.0 | |||||||||
| Earnings From Equity Interest Net Of Tax | -410817.0 | |||||||||
| Fees | -34 M | |||||||||
| Gain On Sale Of Security | 21620.0 | 935752.0 | 3 M | |||||||
| General And Administrative Expense | 6 M | 9 M | 12 M | 20 M | 5 M | 2 M | 11 M | -340000.0 | -220000.0 | -32811.0 |
| Gross Profit Margin (profit Margin After CGS) | 40 M | 9 M | 10 M | 7 M | ||||||
| Impairment Of Capital Assets | 7 M | 39 M | 9 M | |||||||
| Interest Expense Non Operating | -219.0 | -3708.0 | 5249.0 | 10316.0 | 445250.0 | 81823.0 | 729896.0 | 575039.0 | 751074.0 | |
| Interest Expense Operating | 156619.0 | -13370.0 | ||||||||
| Minority Interests | -19041.0 | -33014.0 | -3382.0 | |||||||
| Misc Other Special Charges | 44370.0 | 94396.0 | 4 M | 8 M | -802109.0 | 32316.0 | -3 M | 4995.0 | 16604.0 | -32811.0 |
| Net Income (loss) | -10 M | -17 M | -19 M | -49 M | -7 M | -2 M | -17 M | -9 M | -3 M | -833.0 |
| Net Income Common Stockholders | -10 M | -17 M | -19 M | -49 M | -7 M | -2 M | -19 M | -11 M | -3 M | -833.0 |
| Net Income Continuous Operations | -10 M | -17 M | -18 M | -49 M | -7 M | -2 M | -17 M | -9 M | -3 M | -833.0 |
| Net Income Extraordinary | -3 M | |||||||||
| Net Non Operating Interest Income Expense | 219.0 | 3708.0 | -5249.0 | -10316.0 | -445250.0 | -81823.0 | -729896.0 | -575039.0 | -1 M | |
| Normalized Income | -9 M | |||||||||
| Operating Income | -10 M | -16 M | -27 M | -65 M | -6 M | -2 M | 2 M | -10 M | -4 M | 32811.0 |
| Operating Income Before Depreciation (EBITDA) | -9 M | -17 M | -20 M | -56 M | -6 M | -2 M | -7 M | -8 M | -4 M | -32811.0 |
| Operating Expense | 10 M | 16 M | 20 M | 65 M | 6 M | 2 M | 7 M | -21 M | -12 M | -32811.0 |
| Other Gand A | 6 M | 9 M | 12 M | 20 M | 5 M | 2 M | 11 M | -340000.0 | -220000.0 | -32811.0 |
| Other Impairment Of Capital Assets | -1 M | -900000.0 | ||||||||
| Other Operating Expenses | -7 M | -1 M | ||||||||
| Other Write Off | 34 M | |||||||||
| Otherunder Preferred Stock Dividend | 167029.0 | 328990.0 | 426003.0 | 3 M | 2 M | |||||
| Preferred Stock Dividends | 167029.0 | 328990.0 | 426003.0 | 3 M | 2 M | |||||
| Rent And Landing Fees | -114241.0 | -120667.0 | -30586.0 | -340000.0 | -260000.0 | -340000.0 | -220000.0 | -32811.0 | ||
| Research Expense | 3 M | 7 M | 8 M | 5 M | 174083.0 | |||||
| Restructring And Mn A Income | 1 M | -400000.0 | 2 M | |||||||
| Salaries And Wages | 1 M | 2 M | -7 M | -1 M | ||||||
| Selling And Marketing Expense | 19 M | 9 M | ||||||||
| Selling Expense | 19 M | 9 M | ||||||||
| Total Income Available For Interest Expense (EBIT) | -10 M | -17 M | -20 M | -56 M | -6 M | -2 M | -10 M | -11 M | -6 M | -32811.0 |
| Total Revenues | 40 M | 43 M | 49 M | 36 M | ||||||
| Total Expenses | 10 M | 16 M | 20 M | 65 M | 6 M | 2 M | 7 M | -59 M | -42 M | -32811.0 |
| Total Revenue | 40 M | 9 M | 49 M | 36 M | ||||||
| Amord | 168750.0 | 168754.0 | 168750.0 | 2 M | 120872.0 | -68453.0 | -3 M | -3 M | -1 M | |
| Avgshs | 502900.0 | 143937.0 | 96400.0 | 31489.0 | 7671.0 | 709.0 | 317.0 | 199.0 | 174.0 | 11.0 |
| Avgshsdt | 502900.0 | 143937.0 | 96400.0 | 31489.0 | 7671.0 | 709.0 | 317.0 | 199.0 | 174.0 | |
| Basiceps | -19.04 | -121.35 | -195.0 | -1552.5 | -892.5 | -8490.0 | -61500.0 | -56250.0 | -15750.0 | |
| Basicepscont | -19.04 | -121.35 | -195.0 | -1552.5 | -892.5 | -8490.0 | -61500.0 | -15750.0 | ||
| Cor | -38 M | -29 M | ||||||||
| Depamor | 337489.0 | 343982.0 | 327910.0 | 656643.0 | 120872.0 | 2 M | 3 M | 3 M | 1 M | |
| Dileps | -19.04 | -121.35 | -195.0 | -1552.5 | -892.5 | -8490.0 | -61500.0 | -56250.0 | -15750.0 | |
| Dilepscont | -19.04 | -121.35 | -8490.0 | -61500.0 | -15750.0 | |||||
| Intinc | 1 M | -410817.0 | ||||||||
| Netincdisc | -10 M | -17 M | -19 M | -49 M | -7 M | -2 M | -17 M | -9 M | -3 M | -833.0 |
| Othincexp | -65990.0 | -1 M | 9300.0 | -8 M | 802109.0 | -32316.0 | 3 M | 476128.0 | 2 M | 32811.0 |
| Pretaxinc | -10 M | -17 M | -20 M | -56 M | -7 M | -2 M | -11 M | -11 M | -7 M | -32811.0 |
| Resdev | 3 M | 7 M | 8 M | 5 M | 174083.0 | -55104.0 | ||||
| Restruct | 1 M | -400000.0 | 2 M | |||||||
| Sga | 6 M | 9 M | 12 M | 20 M | 5 M | 2 M | 11 M | 19 M | 9 M | -32811.0 |
| Shsout | 2 M | 486267.0 | 138551.0 | 70113.0 | 25934.0 | 1082.0 | 627.0 | 250.0 | 194.0 | 15 M |
| Specincchg | -1 M | -7 M | -39 M | -9 M | 400000.0 | -2 M | ||||
| Taxprov | 8930.0 | 28913.0 | -1 M | -7 M | 5 M | 388657.0 | 6 M | -2 M | -4 M | 833.0 |